Patrick Jordan has a passion for creating and managing biopharma investments and partnerships.
He has more than 25 years of experience in healthcare across a variety of leadership positions in corporate development, operations, provider services, and technology solutions. Patrick is currently CEO of Mycovia Pharmaceuticals, a late-stage biopharmaceutical company, and partner at NovaQuest Capital Management, a healthcare-focused private equity firm with $2.75 billion of investor capital.
Prior to joining Mycovia and NovaQuest, Patrick led the creation of the next generation of clinical development solutions at IQVIA to transform clinical research, and was a central figure in the merger of IMS Health and Quintiles. He led the operational delivery and strategic growth strategies for IQVIA’s largest customer base, and his team’s managed partnership capability was recognized internationally. An original member of NovaQuest’s founding at Quintiles, he led the group’s investment partnership strategy in Europe.